| 臺大學術典藏 |
2022-03-04T03:48:13Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
WEI-CHOU LIN; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:11Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; WEI-CHOU LIN; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:08Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.; Liu S.-H.; WEI-CHOU LIN; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2022-03-04T03:48:07Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; WEI-CHOU LIN; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-10-08T08:16:25Z |
A competing round-robin prediction model for histologic subtype prediction of lung adenocarcinomas based on thoracic computed tomography
|
Chen L.-W.; Yang S.-M.; Wang H.-J.; MONG-WEI LIN; Chen L.-R.; Hsu F.-S.; Li C.-C.; Chen C.-M. |
| 臺大學術典藏 |
2021-09-02T00:09:14Z |
Development of a respiratory sound labeling software for training a deep learning-based respiratory sound analysis model
|
Hsu F.-S;Huang C.-J;Kuo C.-Y;Huang S.-R;Cheng Y.-R;Wang J.-H;Wu Y.-L;Tzeng T.-L;Lai F.; Hsu F.-S; Huang C.-J; Kuo C.-Y; Huang S.-R; Cheng Y.-R; Wang J.-H; Wu Y.-L; Tzeng T.-L; Lai F.; FEI-PEI LAI |
| 臺大學術典藏 |
2021-09-02T00:04:27Z |
Breathing Sound Segmentation and Detection Using Transfer Learning Techniques on an Attention-Based Encoder-Decoder Architecture
|
Hsiao C.-H;Lin T.-W;Lin C.-W;Hsu F.-S;Lin F.Y.-S;Chen C.-W;Chung C.-M.; Hsiao C.-H; Lin T.-W; Lin C.-W; Hsu F.-S; Lin F.Y.-S; Chen C.-W; Chung C.-M.; CHII-WANN LIN |
| 臺大學術典藏 |
2021-03-18T02:02:24Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-18T02:02:23Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Chia-Tung Shun;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; CHIA-TUNG SHUN; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:55Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-03-04T02:35:54Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Yu-Chieh Tsai;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; YU-CHIEH TSAI; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-01-28T03:15:20Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.;Kuo K.-L.;Chen M.-S.;Po-Ming Chow;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Huang K.-H.; Shi C.-S.; Kuo K.-L.; Chen M.-S.; PO-MING CHOW; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; Huang K.-H. |
| 臺大學術典藏 |
2021-01-28T02:02:55Z |
A Comprehensive Review of US FDA-Approved Immune Checkpoint Inhibitors in Urothelial Carcinoma
|
Hsu F.-S.;Su C.-H.;Kuo-How Huang; Hsu F.-S.; Su C.-H.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:49Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7)
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Chang H.-C.;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Kuo-How Huang; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; Chang H.-C.; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:46Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Chang H.-C.;Kuo-How Huang; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; Chang H.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:45Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Chang H.-C.;Kuo-How Huang; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; Chang H.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:43Z |
Suppression of Angiogenesis by Targeting Cyclin-Dependent Kinase 7 in Human Umbilical Vein Endothelial Cells and Renal Cell Carcinoma: An In Vitro and In Vivo Study
|
Shi C.-S.;Kuo K.-L.;Chen M.-S.;Chow P.-M.;Liu S.-H.;Chang Y.-W.;Lin W.-C.;Liao S.-M.;Hsu C.-H.;Hsu F.-S.;Chang H.-C.;Kuo-How Huang; Shi C.-S.; Kuo K.-L.; Chen M.-S.; Chow P.-M.; Liu S.-H.; Chang Y.-W.; Lin W.-C.; Liao S.-M.; Hsu C.-H.; Hsu F.-S.; Chang H.-C.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:42Z |
Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction
|
Hsu F.-S.;Chou C.-W.;Chang H.-C.;Tu Y.-P.;Sha S.-J.;Chung H.-H.;Kuo-How Huang; Hsu F.-S.; Chou C.-W.; Chang H.-C.; Tu Y.-P.; Sha S.-J.; Chung H.-H.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:42Z |
Author Correction: Comparison of Multipulse Laser Vaporesection versus Plasmakinetic Resection for Treatment of Benign Prostate Obstruction (Scientific Reports, (2019), 9, 1, (6427), 10.1038/s41598-019-42903-6)
|
Hsu F.-S.;Chou C.-W.;Chang H.-C.;Tu Y.-P.;Sha S.-J.;Chung H.-H.;Kuo-How Huang; Hsu F.-S.; Chou C.-W.; Chang H.-C.; Tu Y.-P.; Sha S.-J.; Chung H.-H.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-28T02:02:38Z |
Nasogastric tube decompression is unnecessary in patients undergoing laparoscopic nephroureterectomy for localized upper tract urothelial carcinoma
|
Hsu F.-S.;Huang W.-Y.;Chen Y.-F.;Wu L.-Y.;Wang S.-M.;Kuo-How Huang; Hsu F.-S.; Huang W.-Y.; Chen Y.-F.; Wu L.-Y.; Wang S.-M.; KUO-HOW HUANG |
| 臺大學術典藏 |
2021-01-26T02:27:34Z |
Histone deacetylase inhibitor, trichostatin a, synergistically enhances paclitaxel-induced cytotoxicity in urothelial carcinoma cells by suppressing the ERK pathway
|
Hsu F.-S.;Wu J.-T.;Lin J.-Y.;Yang S.-P.;Kuo K.-L.;Lin W.-C.;Shi C.-S.;Chow P.-M.;Liao S.-M.;Pan C.-I.;Hong J.-Y.;Hong-Chiang Chang;Huang K.-H.; Hsu F.-S.; Wu J.-T.; Lin J.-Y.; Yang S.-P.; Kuo K.-L.; Lin W.-C.; Shi C.-S.; Chow P.-M.; Liao S.-M.; Pan C.-I.; Hong J.-Y.; HONG-CHIANG CHANG; Huang K.-H. |
| 臺大學術典藏 |
2021-01-26T02:27:34Z |
Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma
|
Lin W.-C.;Hsu F.-S.;Kuo K.-L.;Liu S.-H.;Shun C.-T.;Shi C.-S.;Hong-Chiang Chang;Tsai Y.-C.;Lin M.-C.;Wu J.-T.;Kuo Y.;Chow P.-M.;Liao S.-M.;Yang S.-P.;Hong J.-Y.;Huang K.-H.; Lin W.-C.; Hsu F.-S.; Kuo K.-L.; Liu S.-H.; Shun C.-T.; Shi C.-S.; HONG-CHIANG CHANG; Tsai Y.-C.; Lin M.-C.; Wu J.-T.; Kuo Y.; Chow P.-M.; Liao S.-M.; Yang S.-P.; Hong J.-Y.; Huang K.-H. |
| 臺大學術典藏 |
2021-01-26T02:27:33Z |
Trifluoperazine, an antipsychotic drug, effectively reduces drug resistance in cisplatin-resistant urothelial carcinoma cells via suppressing bcl-xl: An in vitro and in vivo study
|
Kuo K.-L.;Liu S.-H.;Lin W.-C.;Hsu F.-S.;Chow P.-M.;Chang Y.-W.;Yang S.-P.;Shi C.-S.;Hsu C.-H.;Liao S.-M.;Hong-Chiang Chang;Huang K.-H.; Kuo K.-L.; Liu S.-H.; Lin W.-C.; Hsu F.-S.; Chow P.-M.; Chang Y.-W.; Yang S.-P.; Shi C.-S.; Hsu C.-H.; Liao S.-M.; HONG-CHIANG CHANG; Huang K.-H. |
